Cargando…

Improvement of respiratory symptoms and health‐related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open‐label study

BACKGROUND: To compare peramivir 300 mg single‐dose, peramivir 600 mg repeat‐dose, and oseltamivir effects on health‐related quality of life, including respiratory symptoms and general conditions, time to symptom alleviation, time to fever resolution, incidence of exacerbations, and virus titer, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kato, Motokazu, Saisho, Yutaka, Tanaka, Hiroshi, Bando, Takuma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404055/ https://www.ncbi.nlm.nih.gov/pubmed/33683019 http://dx.doi.org/10.1111/irv.12835

Ejemplares similares

Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre‐existing chronic respiratory disease: Findings of a randomized, open‐label study
por: Kato, Motokazu, et al.
Publicado: (2020)

Peramivir for influenza
Publicado: (2019)

Safety and efficacy of peramivir for influenza treatment
por: Hata, Atsuko, et al.
Publicado: (2014)

Efficacy and Safety of Intravenous Peramivir Compared With Oseltamivir in High-Risk Patients Infected With Influenza A and B Viruses: A Multicenter Randomized Controlled Study
por: Nakamura, Shigeki, et al.
Publicado: (2017)

Peramivir and laninamivir susceptibility of circulating influenza A and B viruses
por: Leang, Sook-Kwan, et al.
Publicado: (2014)

Peramivir injection in the treatment of acute influenza: a review of the literature
por: Wester, Ashley, et al.
Publicado: (2016)

Single Dose IV Peramivir is Safe and Effective in the Treatment of Pediatric Influenza
por: Vanchiere, John, et al.
Publicado: (2017)

Detection of Peramivir and Laninamivir, New Anti-Influenza Drugs, in Sewage Effluent and River Waters in Japan
por: Azuma, Takashi, et al.
Publicado: (2015)

Clinical Effectiveness of Peramivir in Comparison with Other Neuraminidase Inhibitors in Pediatric Influenza Patients
por: Hikita, Toshiyuki, et al.
Publicado: (2012)

Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections
por: Alame, Malak M., et al.
Publicado: (2016)

A Case of Influenza Associated Fulminant Myocarditis Successfully Treated with Intravenous Peramivir
por: Baik, Seung Hee, et al.
Publicado: (2015)

Clinical Effectiveness and Safety of Peramivir for Influenza Infection: Safe and Effective Antiviral Treatment
por: Lee, Jin Seo
Publicado: (2018)

Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection
por: Pascua, Philippe Noriel Q., et al.
Publicado: (2017)

Clinical Effectiveness of Intravenous Peramivir versus Oseltamivir for the Treatment of Influenza in Hospitalized Patients
por: Lee, Jin Seo, et al.
Publicado: (2020)

Evaluation of Baloxavir Marboxil and Peramivir for the Treatment of High Pathogenicity Avian Influenza in Chickens
por: Twabela, Augustin, et al.
Publicado: (2020)

Peramivir, an Anti-Influenza Virus Drug, Exhibits Potential Anti-Cytokine Storm Effects
por: Zhang, Chen-xi, et al.
Publicado: (2022)

Oseltamivir/peramivir: Lack of efficacy: case report
Publicado: (2020)

Use of Intravenous Peramivir in a Critically Ill Toddler With Influenza A Infection and Cardiac Involvement
por: Chaudhary, Manu, et al.
Publicado: (2015)

Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis
por: Lee, Jonghoo, et al.
Publicado: (2017)

A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment
por: Chen, Jui-Yi, et al.
Publicado: (2020)

Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09
por: Louie, Janice K., et al.
Publicado: (2012)

827 The efficacy of single dose peramivir in acute uncomplicated influenza: an integrated subject-level meta-analysis
por: Whitley, Richard, et al.
Publicado: (2014)

PEPT1-mediated prodrug strategy for oral delivery of peramivir
por: Sun, Yongbing, et al.
Publicado: (2018)

A Retrospective Analysis of Three Antiviral Regimens of Peramivir in the Treatment of Severe Influenza A with Primary Viral Pneumonia
por: Wang, Jin-na, et al.
Publicado: (2019)

Adult influenza A (H3N2) with reduced susceptibility to baloxavir or peramivir cured after switching anti-influenza agents
por: Seki, Masafumi, et al.
Publicado: (2019)

Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model
por: Farooqui, Amber, et al.
Publicado: (2015)

Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data
por: Choi, Won Suk, et al.
Publicado: (2018)

Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice
por: Park, Sehee, et al.
Publicado: (2014)

Clinical Effectiveness of Intravenous Peramivir Compared With Oseltamivir in Patients With Severe Influenza A With Primary Viral Pneumonia: A Randomized Controlled Study
por: Chen, Hong-Dou, et al.
Publicado: (2020)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study
por: Zhang, Yan, et al.
Publicado: (2016)

Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment
por: Li, Zhengtu, et al.
Publicado: (2016)

Intravenous peramivir vs oral oseltamivir in high‐risk emergency department patients with influenza: Results from a pilot randomized controlled study
por: Hsieh, Yu‐Hsiang, et al.
Publicado: (2020)

Intermolecular Mechanism and Dynamic Investigation of Avian Influenza H7N9 Virus’ Susceptibility to E119V-Substituted Peramivir–Neuraminidase Complex
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Impact of the R292K Mutation on Influenza A (H7N9) Virus Resistance towards Peramivir: A Molecular Dynamics Perspective
por: Mtambo, Sphamandla E., et al.
Publicado: (2022)

Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
por: Alcazar-Navarrete, Bernardino, et al.
Publicado: (2020)

Respiratory Symptoms of Vendors in an Open-Air Hawker Center in Brunei Darussalam
por: Nazurah bt Abdul Wahid, Nurul Nor, et al.
Publicado: (2014)

Respiratory Pathogens in Children with and without Respiratory Symptoms
por: van der Zalm, Marieke M., et al.
Publicado: (2009)

Independent-Trajectories Thermodynamic-Integration Free-Energy Changes for Biomolecular Systems: Determinants of H5N1 Avian Influenza Virus Neuraminidase Inhibition by Peramivir
por: Lawrenz, Morgan, et al.
Publicado: (2009)

Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States
por: Hernandez, Jaime E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_05r6h7spd54d3clf6gvpinf19s